Want to join the conversation?
John Inch of Deutsche Bank asks about how much free cash the company would be generating in US. $EMR said it's going to be about 50-50. To profile the company from sales profitability, it does not change much as the company operated going into the transformation. So $EMR is losing operating cash flow around $400-500MM at the generation of $3Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?